Log In
Print
BCIQ
Print
Print this Print this
 

Epoetin alfa (JR-013)

  Manage Alerts
Collapse Summary General Information
Company JCR Pharmaceuticals Co. Ltd.
DescriptionBiosimilar recombinant human erythropoietin (EPO) rDNA origin
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat renal anemia
Regulatory Designation

Partner

GlaxoSmithKline plc; Kissei Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today